肝胆相照论坛

标题: 泰诺福韦乙肝48周中国第3阶段研究 [打印本页]

作者: StephenW 时间: 2013-6-20 20:09 标题: 泰诺福韦乙肝48周中国第3阶段研究

48 Weeks TDF Treatment Results in Potent Viral
Suppression and A Favorable Safety Profile in Chinese
Chronic Hepatitis B Patients

Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL), June 2013,
Singapore

JL Hou1*, ZL Gao2, Q Xie3, JM Zhang4, JF Sheng5, J Cheng6, CW Chen7,
Q Mao8, W Zhao9, H Ren10 , DM Tan11, JQ Niu12, SJ Chen13, C Pan14, H
Tang15, H Wang16, YM Mao17,JD Jia18, Q Ning19, M Xu20, SM Wu20, J Li22,
XX Zhang3; Y Ji23; J Dong24, J Li24

* Corresponding Author: Jin Lin Hou M.D. Director & Professor, Hepatology Unit
and Department of Infectious Disease, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

1Nanfang Hospital, Guangzhou, China; 23rd Affiliated Hospital of Sun Yat-Sen
University, Guangzhou, China; 3Ruijin Hospital Affiliated to Jiaotong University,
Shanghai, China; 4Huashan Hospital Affiliated to Fudan University, Shanghai,
China;51st Affiliated Hospital of ZheJiang University, Hangzhou, China; 6Beijing
Ditan Hospital, Beijing, China; 7Shanghai the 85th Hospital Affiliated to Nanjing
Military, Shanghai, China; 8Southwest Hospital, Third Military Medical University,
Chongqing, China; 92nd Hospital of Nanjing, Nanjing, China; 102nd Affiliated
Hospital Chongqing Medical University, Chongqing, China;11Xiangya Hospital
Central-South University, Changsha, China; 121st Affi liated Hospital of Jilin
University, Changchun, China; 13Jinan Hospital for Infectious Disease, Jinan,
China; 14 Fuzhou Infectious Disease Hospital, Fuzhou, China; 15West China
Hospital, Sichuan University, Chengdu, China; 16Peking University People’s
Hospital, Beijing, China; 17Renji Hospital Affiliated to Shanghai JiaoTong
University, Shanghai, China; 18Beijing Friendship Hospital Affi liated to Capital
University, Beijing, China; 19Tongji Hospital of Tongji Medical College, Wuhan,
China; 20Guangzhou Eighth Municipal People’s Hospital, Guangzhou, China;
21Shanghai Public Health Clinical Center, Shanghai, China; 22The First Affiliated
Hospital with Nanjing Medical University, Nanjing, China; 23Zhongshan Hospital,
Fudan University, Shanghai, China ; 24GlaxoSmithKline R&D China.

CONCLUSIONS

At Week 48, TDF demonstrated high potency and a favorable safety profile in Chinese CHB patients. No TDF resistance was observed.
结论

48周时，TDF展示中国CHB患者高效力和良好的安全性。没有TDF耐药。

作者: 咬牙硬挺 时间: 2013-6-25 11:07

感谢分享，好人一生平安

作者: YY315812102 时间: 2013-7-16 12:54

但愿要价合理？

作者: jsmscym 时间: 2013-7-16 13:13

不知道何时上市

作者: MP4 时间: 2013-7-16 14:40

jsmscym 发表于 2013-7-16 13:13
不知道何时上市

早就上市了

作者: jsmscym 时间: 2013-7-16 15:43

我说的是中国上市

作者: MP4 时间: 2013-7-17 19:19

jsmscym 发表于 2013-7-16 15:43
我说的是中国上市

是啊，中国早上市了啊

作者: 王震宇 时间: 2013-7-17 23:30

我来回答你

大约是2013年10-11月

作者: hunterpt 时间: 2013-7-18 11:27

那只剩几个月了。期盼，不过价格估计不菲。

作者: zttz 时间: 2013-7-27 12:04

回复王震宇的帖子

国产的已经获批
富马酸替诺福韦二吡呋酯 (国药准字H20130087 安徽贝克联合制药有限公司 86907744000054)

批准文号	国药准字H20130087
产品名称	富马酸替诺福韦二吡呋酯
英文名称	Tenofovir Disoproxil Fumarate
商品名
剂型	原料药
规格	----
生产单位	安徽贝克联合制药有限公司
生产地址	安徽省太和工业园区B区工业大道
产品类别	化学药品
原批准文号
批准日期	2013-07-16
药品本位码	86907744000054

作者: jsmscym 时间: 2013-7-27 12:58

我查过了，确实有此事。http://app1.sfda.gov.cn/datasear ... =TABLE25&title=国产药品&bcId=124356560303886909015737447882

作者: MP4 时间: 2013-7-27 16:30

zttz 发表于 2013-7-27 12:04
回复王震宇的帖子

国产的已经获批

原料药,一次一桶,你要吃几公斤?

作者: jsmscym 时间: 2013-7-27 19:50

不知道国产后价格会不会更低点

作者: jsmscym 时间: 2013-7-27 19:53

http://app1.sfda.gov.cn/datasear ... =TABLE25&title=国产药品&bcId=124356560303886909015737447882

作者: MP4 时间: 2013-7-28 04:39

jsmscym 发表于 2013-7-27 19:50
不知道国产后价格会不会更低点

都还没有批准就别瞎想

作者: 山东小兵 时间: 2013-9-28 16:12

回复 zttz 的帖子

回头看看价格

欢迎光临肝胆相照论坛 (http://hbvhbv.info/forum/)